830P Subanalysis of a randomized phase III study comparing trabectedin and PLD vs PLD alone in patients with recurrent ovarian cancer (ROC)

Autor: Monk, B.J., Herzog, T., McGowan, T., De Rivas Otero, B., Gomez, J., Tanovic, A., Coleman, R.L.
Zdroj: In Annals of Oncology September 2020 31 Supplement 4:S625-S625
Databáze: ScienceDirect